Evaluation of Physical and Functional Status in Patients With COVID-19 in Long Term

Sponsor
Hacettepe University (Other)
Overall Status
Completed
CT.gov ID
NCT04836767
Collaborator
(none)
40
1
11.6
3.5

Study Details

Study Description

Brief Summary

The reason the investigators want to do this research; Especially after Covid-19 infection, no research has been found on functional status in the long term. Therefore, in our study, the investigators aimed to evaluate exercise capacity, functional status, peripheral muscle strength, balance, anxiety and depression level, consciousness, work productivity, pain, fear of movement, and quality of life in patients with Covid-19 and to compare them with healthy individuals who have not had COVID-19.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    In our study, the investigators aimed to evaluate long-term exercise capacity, functional status, peripheral muscle strength, balance, anxiety and depression level, cognitive status, pain, kinesophobia and quality of life in patients with COVID-19, and to compare them with healthy individuals who have not had COVID-19. Our second goal; It is the evaluation of the relationship between long-term exercise capacity, pain, kinesiophobia, peripheral muscle strength, balance, anxiety and depression level, cognitive status and quality of life in individuals with COVID-19. It will also be examined whether these parameters change according to the post-COVID functional restriction level.

    1. Materials and Methods of the Research: 3.1. The place of the study: Cardiopulmonary Rehabilitation Unit of Hacettepe University Faculty of Physical Therapy and Rehabilitation and Hacettepe University Faculty of Medicine Department of General Internal Medicine

    3.2. Time of the study: It is planned to collect data and write the study between February 2021 and February 2022.

    3.3. Research population, sample, research group:

    The population of the study is individuals who have passed the diagnosis of COVID-19 for at least 12 weeks and healthy individuals who have not had COVID-19.

    The sample of the study is individuals in the long-term after the diagnosis of COVID-19 at least 12 weeks after the diagnosis of COVID-19 in Hacettepe University Adult Hospital who meet the inclusion criteria and volunteer to participate in the study, and healthy individuals who have not had COVID-19.

    Study Design:

    Individuals meeting the inclusion criteria will be included in the study. The study will be conducted with people between the ages of 18-65, whose education level is at least primary school, and whose local language is Turkish. A total of 40 participants, 20 healthy without COVID-19, and 20 with at least 12 weeks past the diagnosis of COVID-19, will be included in the study. The guidance of the participants will be provided by the relevant physicians of the General Internal Medicine Unit of Hacettepe University Internal Diseases Department.

    In accordance with the COVID-19 pandemic precautions, social distance rules will be followed in the tests to be carried out with individuals, care will be taken to use masks, and the materials to be used in tests and measurements will be disinfected before and after use.

    COVID-19 Group Inclusion Criteria

    • Having been diagnosed with COVID-19 at least 12 weeks ago,

    • Being literate,

    • Being in the age range of 18-65,

    • Volunteering to participate in research,

    • To be clinically stable, to be under control if any accompanying comorbid conditions (such as hypertension, diabetes),

    • Not having any orthopedic and neurological problems that might interfere with evaluating peripheral muscle strength, balance and exercise capacity.

    COVID-19 Group Exclusion Criteria

    • Those with an ICU hospitalization history due to the diagnosis of COVID-19,

    • Recent myocardial infarction and pulmonary embolism.

    • Having accompanying chronic diseases,

    • Those who have any orthopedic or neurological disorders that will prevent walking,

    • Another COVID-19 PCR Test positivity in the last 12 weeks,

    • Not being able to cooperate and adapt to exercise test due to neurological influences such as cerebrovascular disease or psychiatric disorders,

    Healthy Group Inclusion Criteria

    • Not having COVID-19,

    • Being literate,

    • Being in the age range of 18-65,

    • Volunteering to participate in research.

    The Criteria for Not Including the Healthy Group in the Study

    • Those who have any orthopedic or neuromuscular disorders that will prevent walking,

    • Having any chronic illness or psychiatric conditions or mental afflictions that may interfere with cooperation or compliance with exercise tests.

    Individuals participating in the study will be informed verbally and in writing about the study protocol and informed consent form will be obtained.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    40 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of Exercise Capacity, Peripheral Muscle Strength, Balance, Cognitive Status and Quality of Life in Patients With COVID-19 in Long Term
    Actual Study Start Date :
    Feb 16, 2021
    Actual Primary Completion Date :
    Feb 3, 2022
    Actual Study Completion Date :
    Feb 3, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    people with a history of COVID-19

    COVID-19 Group Inclusion Criteria Having been diagnosed with COVID-19 at least 12 weeks ago, Being literate, Being in the age range of 18-65, Volunteering to participate in research, To be clinically stable, to be under control if any accompanying comorbid conditions (such as hypertension, diabetes), Not having any orthopedic and neurological problems that might interfere with evaluating peripheral muscle strength, balance and exercise capacity. COVID-19 Group Exclusion Criteria Those with an ICU hospitalization history due to the diagnosis of COVID-19, Recent myocardial infarction and pulmonary embolism. Having accompanying chronic diseases, Those who have any orthopedic or neurological disorders that will prevent walking, Another COVID-19 PCR Test positivity in the last 12 weeks, Not being able to cooperate and adapt to exercise test due to neurological influences such as cerebrovascular disease or psychiatric disorders,

    healthy people

    Healthy Group Inclusion Criteria Not having COVID-19, Being literate, Being in the age range of 18-65, Volunteering to participate in research. The Criteria for Not Including the Healthy Group in the Study Those who have any orthopedic or neuromuscular disorders that will prevent walking, Having any chronic illness or psychiatric conditions or mental afflictions that may interfere with cooperation or compliance with exercise tests.

    Outcome Measures

    Primary Outcome Measures

    1. Incremental shuttle walking test [January,2021 - December,2021]

      It assesses maximal exercise capacity.

    Secondary Outcome Measures

    1. Time up and Go Test [January,2021 - December,2021]

      Functional balance and walking capacity

    2. Short form McGill-Melzack Pain Questionnaire [January,2021 - December,2021]

      The pain rating index has 2 subscales: Sensory subscale with 11 words, and Affective subscale with 4 words. These words or items are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate and 3 = severe. There's also one item for present pain intensity and one item for a 10 cm visual analogue scale (VAS) for average pain. The higher the total score on the MPQ, the more the pain experience for the patient increases

    3. Tampa Kinesophobia Questionnaire [January,2021 - December,2021]

      Assessment of fear of movement. Scores range from 17-68. Higher scores indicate higher level of kinesiophobia

    4. Hospital Anxiety and Depression Scale [January,2021 - December,2021]

      Assessment of anxiety and depression. Scores range from 0 to 21 for each of the two subscales. Higher scores indicate higher level of anxiety and depression

    5. SF-36 Quality of Life Scale [January,2021 - December,2021]

      Assessment of life quality. The scores of each domain ranges from zero to 100 which higher scores indicating higher levels of functioning or well-being

    6. Fatigue Severity Scale [January,2021 - December,2021]

      Assessment of fatigue perception. Scores range from 0-7. Scores higher than 4 indicate severe fatigue perception.

    7. Cognitive Status Scale [January,2021 - December,2021]

      Assessment of cognitive status. Score ranges from 0-100. Higher scores indicate increased tendency to cognitive failure.

    8. Body Mass Index [January,2021 - December,2021]

      Body mass index (BMI) is a measure of body fat based on height and weight that applies to adult men and women.

    9. Body composition analysis with bioelectrical impedance analysis system [January,2021 - December,2021]

      FM and FFM ratio

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    COVID-19 Group Inclusion Criteria

    • Having been diagnosed with COVID-19 at least 12 weeks ago,

    • Being literate,

    • Being in the age range of 18-65,

    • Volunteering to participate in research,

    • To be clinically stable, to be under control if any accompanying comorbid conditions (such as hypertension, diabetes),

    • Not having any orthopedic and neurological problems that might interfere with evaluating peripheral muscle strength, balance and exercise capacity.

    COVID-19 Group Exclusion Criteria Those with an ICU hospitalization history due to the diagnosis of COVID-19,

    • Recent myocardial infarction and pulmonary embolism.

    • Having accompanying chronic diseases,

    • Those who have any orthopedic or neurological disorders that will prevent walking,

    • Another COVID-19 PCR Test positivity in the last 12 weeks,

    • Not being able to cooperate and adapt to exercise test due to neurological influences such as cerebrovascular disease or psychiatric disorders, Healthy Group Inclusion Criteria

    • Not having COVID-19,

    • Being literate,

    • Being in the age range of 18-65,

    • Volunteering to participate in research. The Criteria for Not Including the Healthy Group in the Study

    • Those who have any orthopedic or neuromuscular disorders that will prevent walking,

    • Having any chronic illness or psychiatric conditions or mental afflictions that may interfere with cooperation or compliance with exercise tests.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hacettepe University Ankara Turkey

    Sponsors and Collaborators

    • Hacettepe University

    Investigators

    • Study Director: Gülay Sain-Guven, Professor, Hacettepe University, Faculty of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ebru Calik Kutukcu, Associate Professor, Hacettepe University
    ClinicalTrials.gov Identifier:
    NCT04836767
    Other Study ID Numbers:
    • GO21-178
    First Posted:
    Apr 8, 2021
    Last Update Posted:
    Aug 9, 2022
    Last Verified:
    Aug 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ebru Calik Kutukcu, Associate Professor, Hacettepe University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 9, 2022